David Campbell
2021
In 2021, David Campbell earned a total compensation of $8.4M as President and Chief Executive Officer at Janux Therapeutics, a 936% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $229,527 |
|---|---|
| Option Awards | $7,721,848 |
| Salary | $459,054 |
| Total | $8,410,429 |
Campbell received $7.7M in option awards, accounting for 92% of the total pay in 2021.
Campbell also received $229.5K in non-equity incentive plan and $459.1K in salary.
Rankings
In 2021, David Campbell's compensation ranked 1,352nd out of 12,406 executives tracked by ExecPay. In other words, Campbell earned more than 89.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,352 out of 12,406 | 89th |
Division Manufacturing | 484 out of 5,492 | 91st |
Major group Chemicals And Allied Products | 176 out of 2,368 | 93rd |
Industry group Drugs | 147 out of 2,089 | 93rd |
Industry Pharmaceutical Preparations | 97 out of 1,536 | 94th |
Source: SEC filing on April 29, 2022.
Campbell's colleagues
We found two more compensation records of executives who worked with David Campbell at Janux Therapeutics in 2021.